2025 年全球先進藥物傳輸系統市場報告

預計未來幾年先進藥物傳輸系統市場規模將強勁成長。到 2029 年，這一數字將成長至 4,042.6 億美元，複合年成長率為 8.9%。預測期內的成長可歸因於患者友善的給藥途徑、對罕見疾病的關注、數位健康整合、以患者為中心的藥物開發、遠端保健的影響、基因治療和 RNA 治療、基於外泌體的藥物輸送、遠端監控設備等。預測期內的主要趨勢包括奈米技術的進步、智慧藥物傳輸系統、藥物製劑的 3D 列印、人工智慧的整合以及永續的藥物傳輸。

慢性病的增加預計將推動先進藥物輸送系統市場的擴張。慢性疾病是指持續時間超過一年且需要持續醫療照護的疾病，它是由多種危險行為引起的，包括吸菸、接觸二手菸、營養不良、缺乏身體活動和過量飲酒。先進的藥物輸送系統在將治療藥物精確地輸送到受慢性疾病影響的特定部位、提高療效和最大限度地減少副作用方面發揮著至關重要的作用。例如，聯合國（UN）2023年5月的資料顯示，慢性病占美國死亡人數的十分之七，每年導致超過170萬人死亡。因此，慢性病發病率的不斷上升推動了先進藥物輸送系統市場的成長。

個人化醫療趨勢可望推動先進藥物輸送系統市場的發展。個人化醫療，也稱為精準醫療，考慮到個人在基因、環境和生活方式方面的差異，提供客製化的醫療服務。先進的藥物傳遞系統有助於將藥物精確地輸送到患病細胞和組織，減少對健康器官的暴露並最大限度地減少副作用。 2023年2月，個人化醫療聯盟報告稱，個人化醫療佔2022年美國食品藥物管理局（FDA）核准的新藥的34%，較前8年大幅成長。因此，對個人化醫療的日益傾向正在推動先進藥物輸送系統市場的發展。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球先進藥物輸送系統 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球先進藥物輸送系統市場：成長率分析
• 全球先進藥物輸送系統市場表現：規模與成長，2019 年至 2024 年
• 全球先進藥物傳輸系統市場預測：規模與成長，2024-2029 年，2034 年預測
• 先進藥物輸送系統的全球總目標市場 (TAM)

第6章 市場細分

• 全球先進藥物輸送系統市場類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 口服藥物傳輸系統
• 注射藥物輸送系統
• 吸入或肺部給藥系統
• 經皮給藥系統
• 粘膜給藥系統
• 基於載體的藥物傳輸系統
• 其他類型
• 全球先進藥物輸送系統市場（按載體類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 脂質體
• 奈米粒子
• 微球
• 單株抗體
• 其他承運商類型
• 全球先進藥物輸送系統市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 前驅藥物
• 植入和子宮內避孕器
• 靶向藥物輸送
• 聚合物藥物輸送
• 其他技術
• 全球先進藥物傳輸系統市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 心血管疾病
• 腫瘤學
• 泌尿系統
• 糖尿病
• CNS（中樞神經系統）
• 眼科
• 發炎性疾病
• 感染疾病
• 其他用途
• 全球先進藥物輸送系統市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院
• 專科門診
• 臨床研究發展中心
• 全球先進藥物輸送系統市場，按口服藥物輸送系統類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
• 固態劑型
• 液體劑型
• 新型口服給藥系統
• 全球先進藥物輸送系統市場，依注射式藥物輸送系統類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 傳統注射系統（注射器、管瓶）
• 預填充式注射器
• 自動注射器
• 基於微針的系統
• 全球先進藥物輸送系統市場，依吸入或肺部藥物輸送系統類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 定量噴霧吸入器(MDI)
• 乾粉吸入器 (DPI)
• 噴霧器
• 緩霧吸入器
• 全球先進藥物輸送系統市場按經皮藥物輸送系統類型細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
• 經皮吸收貼片
• 微針貼片
• 離子電滲系統
• 全球先進藥物傳輸系統市場，依粘膜藥物傳遞系統類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 口服給藥系統
• 舌下給藥系統
• 鼻腔給藥系統
• 直腸輸送系統
• 全球先進藥物傳輸系統市場，依載體藥物傳遞系統類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 脂質體
• 奈米粒子
• 樹狀聚合物
• 囊泡
• 全球先進藥物輸送系統市場，按類型細分，實際及預測，2019-2024 年，2024-2029 年，2034 年
• 植入式藥物傳輸系統
• 標靶遞送系統
• 生物黏附藥物傳輸系統

第7章 區域和國家分析

• 全球先進藥物輸送系統市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球先進藥物輸送系統市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 先進藥物輸送系統市場：競爭格局
• 先進藥物輸送系統市場：公司簡介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Novartis AG
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• 3M Company
• Medtronic plc
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• Amgen Inc.
• Merck Group
• Becton Dickinson and Company
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi SA
• Boston Scientific Corporation

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年先進藥物輸送系統市場：提供新機會的國家
• 2029 年先進藥物輸送系統市場：提供新機會的細分市場
• 先進藥物輸送系統市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Advanced drug delivery systems refer to innovative techniques and formulations designed to enhance the targeted distribution, bioavailability, and efficacy of pharmaceutical medications. These systems aim to maximize drug efficacy while minimizing side effects, providing controlled drug release rates, and targeting specific areas of the body.

The main types of advanced drug delivery systems include oral drug delivery systems, injection-based drug delivery systems, inhalation or pulmonary drug delivery systems, transdermal drug delivery systems, transmucosal drug delivery systems, carrier-based drug delivery systems, and others. The oral drug delivery system involves introducing a chemical through the mouth or into the gastrointestinal tract for systemic activity. Carrier types in these systems include liposomes, nanoparticles, microspheres, monoclonal antibodies, and others. Various technologies, such as prodrugs, implants, intrauterine devices, targeted drug delivery, polymeric drug delivery, and others, are employed. These delivery systems find applications in indications such as cardiovascular diseases, oncology, urology, diabetes, central nervous system (CNS) disorders, ophthalmology, inflammatory diseases, infections, and more. They are utilized by hospitals, specialized clinics, and clinical research and development centers.

The advanced drug delivery systems research report is one of a series of new reports from The Business Research Company that provides advanced drug delivery systems market statistics, including the advanced drug delivery systems industry's global market size, regional shares, competitors with advanced drug delivery systems market share, detailed advanced drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the advanced drug delivery systems industry. This advanced drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The advanced drug delivery systems market size has grown strongly in recent years. It will grow from $269.99 billion in 2024 to $287.82 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to improved patient compliance, drug patent expirations, personalized medicine, chronic disease prevalence, biologics and large molecule drugs

The advanced drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $404.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to patient-friendly routes of administration, focus on rare diseases, digital health integration, patient-centric drug development, telehealth influence, gene therapy and rna therapeutics, exosome-based drug delivery, remote monitoring devices. Major trends in the forecast period include nanotechnology advancements, smart drug delivery systems, 3d printing in drug formulations, integration of artificial intelligence, sustainable drug delivery.

The anticipated rise in chronic conditions is poised to drive the expansion of the advanced drug delivery systems market. Chronic conditions, persisting for a year or longer and necessitating ongoing medical care, are attributed to various risk behaviors such as tobacco use, exposure to secondhand smoke, poor nutrition, physical inactivity, and excessive alcohol use. Advanced drug delivery systems play a crucial role in precisely delivering therapeutic agents to specific sites affected by chronic conditions, enhancing drug effectiveness, and minimizing side effects. For example, as per May 2023 data from The United Nations (UN), chronic diseases account for seven out of 10 deaths in the US, causing over 1.7 million fatalities annually. Consequently, the increasing prevalence of chronic conditions underpins the growth of the advanced drug delivery systems market.

The shifting trend towards personalized medicine is anticipated to fuel the advancement of the advanced drug delivery systems market. Personalized medicine, also known as precision medicine, considers individual differences in genes, environments, and lifestyles for tailored medical care. Advanced drug delivery systems are instrumental in directing drugs precisely to diseased cells or tissues, reducing exposure to healthy organs and minimizing side effects. In February 2023, according to the Personalized Medicine Coalition, personalized drugs constituted 34% of new pharmaceuticals approved by the US Food and Drug Administration in 2022, marking a significant increase from the previous eight years. Therefore, the growing inclination towards personalized medicine is a driving force for the advanced drug delivery systems market.

Technological advancements represent a prominent trend in the advanced drug delivery systems market, with major companies embracing new technologies to maintain their market positions. In June 2023, Shilpa Medicare Limited, an India-based manufacturer and supplier of API and formulations, introduced Molshil, the world's first oral thin film formulation of a pediatric dose of paracetamol. This innovative paracetamol formulation boasts high palatability, ease of administration, and eliminates some disadvantages associated with pediatric formulations.

Major companies in the advanced drug delivery systems market are prioritizing strategic partnerships, such as those focused on indigenous drug delivery systems, to enhance efficacy and accessibility. These collaborations emphasize innovation and streamlined development processes. An indigenous drug delivery system leverages local resources and traditional knowledge to effectively administer therapeutic agents, prioritizing biocompatibility and cultural relevance, which can improve health outcomes in specific populations. For example, in June 2022, Gufic Biosciences, an India-based pharmaceutical company, introduced a Dual Chamber Bag (DCB). This system enhances drug delivery by ensuring safety and stability through a sterile, user-friendly design that reduces the risk of contamination and dosing errors. It also promotes indigenous production, making healthcare more affordable while improving the efficacy of reconstituted medications.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc., a US-based specialty pharmaceutical firm. Through this acquisition, Halozyme aims to strengthen its position as a top drug delivery firm, expanding its approach to covering specialized goods with its best-in-class auto-injector technology and specialty commercial business.

Major companies operating in the advanced drug delivery systems market include Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG, Novartis AG, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Mylan N.V., Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation

North America was the largest region in the advanced drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the advanced drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The advanced drug delivery systems market consists of revenues earned by entities by providing stimuli-responsive drug delivery systems, sustained drug delivery systems, targeted drug delivery systems, and nanoparticle-based drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced drug delivery systems market also consists of sales of fentanyl transdermal patches, albuterol inhalers, and hydrogels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation Or Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System; Other Types
• 2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
• 3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
• 4) By Application: Cardiovascular Diseases; Oncology; Urology; Diabetes; CNS (Central Nervous System); Ophthalmology; Inflammatory Diseases; Infections; Other Applications
• 5) By End User: Hospitals; Specialized clinics; Clinical Research And Development Centers
• Subsegments:
• 1) By Oral Drug Delivery System: Solid Dosage Forms; Liquid Dosage Forms; Novel Oral Delivery Systems
• 2) By Injection-Based Drug Delivery System: Conventional Injection Systems (Syringes, Vials); Prefilled Syringes; Autoinjectors; Microneedle-Based Systems
• 3) By Inhalation Or Pulmonary Drug Delivery System: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers; Soft Mist Inhalers
• 4) By Transdermal Drug Delivery System: Transdermal Patches; Microneedle Patches; Iontophoresis Systems
• 5) By Transmucosal Drug Delivery System: Buccal Delivery Systems; Sublingual Delivery Systems; Nasal Delivery Systems; Rectal Delivery Systems
• 6) By Carrier-Based Drug Delivery System: Liposomes; Nanoparticles; Dendrimers; Niosomes
• 7) By Other Types: Implantable Drug Delivery Systems; Targeted Delivery Systems; Bioadhesive Drug Delivery Systems
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; Abbvie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Drug Delivery Systems Market Characteristics

3. Advanced Drug Delivery Systems Market Trends And Strategies

4. Advanced Drug Delivery Systems Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Advanced Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Advanced Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Advanced Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Advanced Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Advanced Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Advanced Drug Delivery Systems Total Addressable Market (TAM)

6. Advanced Drug Delivery Systems Market Segmentation

• 6.1. Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Drug Delivery System
• Injection-Based Drug Delivery System
• Inhalation Or Pulmonary Drug Delivery System
• Transdermal Drug Delivery System
• Transmucosal Drug Delivery System
• Carrier-Based Drug Delivery System
• Other Types
• 6.2. Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liposomes
• Nanoparticles
• Microspheres
• Monoclonal Antibodies
• Other Carrier Types
• 6.3. Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prodrug
• Implants And Intrauterine Devices
• Targeted Drug Delivery
• Polymeric Drug Delivery
• Other Technologies
• 6.4. Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Diseases
• Oncology
• Urology
• Diabetes
• CNS (Central Nervous System)
• Ophthalmology
• Inflammatory Diseases
• Infections
• Other Applications
• 6.5. Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialized clinics
• Clinical Research And Development Centers
• 6.6. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Oral Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Dosage Forms
• Liquid Dosage Forms
• Novel Oral Delivery Systems
• 6.7. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Injection-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Injection Systems (Syringes, Vials)
• Prefilled Syringes
• Autoinjectors
• Microneedle-Based Systems
• 6.8. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Inhalation Or Pulmonary Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered-Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• Soft Mist Inhalers
• 6.9. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transdermal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Patches
• Microneedle Patches
• Iontophoresis Systems
• 6.10. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transmucosal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Delivery Systems
• Sublingual Delivery Systems
• Nasal Delivery Systems
• Rectal Delivery Systems
• 6.11. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Carrier-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liposomes
• Nanoparticles
• Dendrimers
• Niosomes
• 6.12. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable Drug Delivery Systems
• Targeted Delivery Systems
• Bioadhesive Drug Delivery Systems

7. Advanced Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Advanced Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Advanced Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Advanced Drug Delivery Systems Market

• 8.1. Asia-Pacific Advanced Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Advanced Drug Delivery Systems Market

• 9.1. China Advanced Drug Delivery Systems Market Overview
• 9.2. China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Advanced Drug Delivery Systems Market

• 10.1. India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Advanced Drug Delivery Systems Market

• 11.1. Japan Advanced Drug Delivery Systems Market Overview
• 11.2. Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Advanced Drug Delivery Systems Market

• 12.1. Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Advanced Drug Delivery Systems Market

• 13.1. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Advanced Drug Delivery Systems Market

• 14.1. South Korea Advanced Drug Delivery Systems Market Overview
• 14.2. South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Advanced Drug Delivery Systems Market

• 15.1. Western Europe Advanced Drug Delivery Systems Market Overview
• 15.2. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Advanced Drug Delivery Systems Market

• 16.1. UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Advanced Drug Delivery Systems Market

• 17.1. Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Advanced Drug Delivery Systems Market

• 18.1. France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Advanced Drug Delivery Systems Market

• 19.1. Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Advanced Drug Delivery Systems Market

• 20.1. Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Advanced Drug Delivery Systems Market

• 21.1. Eastern Europe Advanced Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Advanced Drug Delivery Systems Market

• 22.1. Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Advanced Drug Delivery Systems Market

• 23.1. North America Advanced Drug Delivery Systems Market Overview
• 23.2. North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Advanced Drug Delivery Systems Market

• 24.1. USA Advanced Drug Delivery Systems Market Overview
• 24.2. USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Advanced Drug Delivery Systems Market

• 25.1. Canada Advanced Drug Delivery Systems Market Overview
• 25.2. Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Advanced Drug Delivery Systems Market

• 26.1. South America Advanced Drug Delivery Systems Market Overview
• 26.2. South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Advanced Drug Delivery Systems Market

• 27.1. Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Advanced Drug Delivery Systems Market

• 28.1. Middle East Advanced Drug Delivery Systems Market Overview
• 28.2. Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Advanced Drug Delivery Systems Market

• 29.1. Africa Advanced Drug Delivery Systems Market Overview
• 29.2. Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Advanced Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Advanced Drug Delivery Systems Market Competitive Landscape
• 30.2. Advanced Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Advanced Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. GlaxoSmithKline plc
• 31.5. 3M Company
• 31.6. Medtronic plc
• 31.7. Eli Lilly and Company
• 31.8. Boehringer Ingelheim GmbH
• 31.9. Amgen Inc.
• 31.10. Merck Group
• 31.11. Becton Dickinson and Company
• 31.12. Baxter International Inc.
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Sanofi S.A.
• 31.15. Boston Scientific Corporation

32. Global Advanced Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Advanced Drug Delivery Systems Market

34. Recent Developments In The Advanced Drug Delivery Systems Market

35. Advanced Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Advanced Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Advanced Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Advanced Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer